90,95 €
90,95 €
inkl. MwSt.
Sofort per Download lieferbar
45 °P sammeln
90,95 €
Als Download kaufen
90,95 €
inkl. MwSt.
Sofort per Download lieferbar
45 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
90,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
45 °P sammeln
A seminal resource since the first edition was published in 1986, Schatzberg's Manual of Clinical Psychopharmacology has distinguished itself, from the very beginning, for its readability and comprehensive approach to the field. This tenth edition builds on that legacy, providing a thorough understanding of evolving treatments and medications. Blending evidence-based information with practical, real-world experience, this accessible volume examines the efficacy, dosing, and side effects of drug classes such as antidepressants, antipsychotic medications, mood stabilizers, and stimulants.
Key features of this edition include the following: . Updated information on newly FDA-approved agents such as vesicular monoamine transporter type-2 inhibitors for tardive dyskinesia, as well as those in late-stage review. A new chapter on pharmacogenomic testing and other commercially available tests designed to help clinicians select appropriate medications for their patients. Quick-reference summary tables on psychotropic classes for swift access to essential information, facilitating informed decision-making in clinical practice. A comprehensive list of suggested readings for each chapter, opening the door to further study and exploration
Additional sections also discuss approaches to treatment-resistant disorders, pharmacotherapy for substance use disorders, and working in specific settings and with special populations-including emergency department treatment and treating pregnant patients, children, and individuals from minority and marginalized communities.
With its unrivaled wealth of information, Schatzberg's Manual of Clinical Psychopharmacology remains a trusted, indispensable resource for clinicians seeking the latest advancements in psychopharmacology, arming them with the knowledge they will need to navigate with confidence the intricacies of psychotropic medications.
Key features of this edition include the following: . Updated information on newly FDA-approved agents such as vesicular monoamine transporter type-2 inhibitors for tardive dyskinesia, as well as those in late-stage review. A new chapter on pharmacogenomic testing and other commercially available tests designed to help clinicians select appropriate medications for their patients. Quick-reference summary tables on psychotropic classes for swift access to essential information, facilitating informed decision-making in clinical practice. A comprehensive list of suggested readings for each chapter, opening the door to further study and exploration
Additional sections also discuss approaches to treatment-resistant disorders, pharmacotherapy for substance use disorders, and working in specific settings and with special populations-including emergency department treatment and treating pregnant patients, children, and individuals from minority and marginalized communities.
With its unrivaled wealth of information, Schatzberg's Manual of Clinical Psychopharmacology remains a trusted, indispensable resource for clinicians seeking the latest advancements in psychopharmacology, arming them with the knowledge they will need to navigate with confidence the intricacies of psychotropic medications.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.